Octreotide 30 MG Injection [Sandostatin]

Known as: OCTREOTIDE ACETATE 5 mg in 1 mL INTRAMUSCULAR INJECTION, POWDER, FOR SUSPENSION [Sandostatin LAR Depot], SandoSTATIN 30 MG Injection, Sandostatin LAR Depot Demonstration Kit KIT 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
UNLABELLED Although numerous treatment modalities have been explored in patients with advanced HCC, the therapeutic options are… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2007
2007
OBJECTIVE:In patients with cirrhosis, acute octreotide administration may transiently decrease the hepatic venous pressure… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2003
2003
BACKGROUND Somatostatin analogues are the best therapy for controlling the symptoms of malignant carcinoid syndrome. Octreotide… (More)
Is this relevant?
2003
2003
INTRODUCTION Depot preparations of long-acting somatostatin analogues are being used increasingly in the treatment of GH… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Although various types of treatment of hepatocellular carcinoma (HCC) have been tried, the prognosis remains dismal, especially… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Cardiovascular disease is the most severe complication of acromegaly accounting for the increased mortality of these patients… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
1997
Highly Cited
1997
We have evaluated the long term effects and safety of Sandostatin LAR, a long acting formulation of octreotide, during 18… (More)
Is this relevant?
1996
1996
Double-blind, single-dose studies of 120 acromegalic patients given 10, 20, and 30 mg Sandostatin LAR (Sandoz Pharma Ltd, Basel… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
A stable and sustained suppression of growth hormone (GH) secretion was noted in 101 patients treated long term with individual… (More)
Is this relevant?
1993
1993
A prospective study was performed to determine the efficacy of octreotide (Sandostatin®; SMS 201–995) 200 μg tid in controlling… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?